DIBIASE MARY (Chief Operating Officer) sold 4.3% of their position (22.26K shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $10.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/27/2025ACC: 0001628280-25-002706
Officer· Chief Operating Officer
Since Sep 2021
+38.92K
Net shares
Net buyer
$10.1K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
61.18K acquired · 22.26K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+61.18K
Price / share
—
Trade value
—
% of position
13.5%
1/23/2025
452.06K→513.24K
Common Stock
Direct
Shares
−22.26K
Price / share
$0.45
Trade value
$10.09K
% of position
4.3%
1/24/2025
513.24K→490.98K
Total
Net shares
+38.92K
Net value
-$10.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2025 | A · Award | +61.18K | — | — | 13.5% | 452.06K | 513.24K |
| Common Stock Direct | 1/24/2025 | S · Sale | −22.26K | $0.45 | $10.09K | 4.3% | 513.24K | 490.98K |
| Total | +38.92K | -$10.09K | ||||||
Derivative Transactions0
No derivative transactions reported